Collaboration agreement for heart, lung and blood disease indicationsCollaboration Agreement • July 7th, 2024
Contract Type FiledJuly 7th, 2024This broad collaboration spans from early research studies, to drug development and big data analysis including real-world evidence studies. In addition to the research partnership, Bayer will be supporting an independent investigator-initiated clinical trial in sickle cell disease.